Physician
Athar, Mohammed
Athar, Mohammed was paid $186K by Medicaid between Jan 2018 and Dec 2020, across 14 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 72% of everything it billed.
33Billing provider infoATHAR, MOHAMMED
MT AIRY, NC 27030
MT AIRY, NC 27030
33aNPI1902899198assigned 08/24/2005
33bProvider typeFamily Medicine Physician
28Total paid$186K
24GClaims5,269
24DCodes billed14
24AFirst – last monthJan 2018 – Dec 2020
Compared with peers
Next to other Family Medicine Physician providers in North Carolina
Rank by total paid#436 of 960
Median peer was paid$135K
This provider vs. median1.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,564 | $74K | |
| 2019 | 1,409 | $59K | |
| 2020 | 1,296 | $52K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 72% | 1,695 | 1,173 | $133K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 1,978 | 1,328 | $35K |
| 94060 | 4.3% | 304 | 284 | $8K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 2.8% | 42 | 42 | $5K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 84 | 72 | $835.88 |
| 93000 | <1% | 107 | 98 | $798.92 | |
| 90756 | <1% | 139 | 132 | $798.00 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 570 | 525 | $773.74 |
| 80305 | <1% | 94 | 92 | $506.04 | |
| 81000 | <1% | 142 | 119 | $220.97 | |
| G0008 | Administration of influenza virus vaccine | <1% | 56 | 54 | $78.49 |
| 36416 | <1% | 17 | 16 | $32.23 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.